E Brouwer
Overview
Explore the profile of E Brouwer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
103
Citations
1922
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Brouwer E, van der Laken J, Visser K, Eizenga W, Mulder D, Sandovici M
Ned Tijdschr Geneeskd
. 2024 Nov;
168.
PMID: 39606882
Giant cell arteritis is a rare disease that can lead to blindness in people older than 50 years. Early recognition and timely treatment can prevent irreversible damage. Early recognition can...
2.
McKimm J, Balasooriya C, Fyfe M, Aboulsoud S, Brouwer E, Nadkar A
Med Teach
. 2024 Aug;
:1-8.
PMID: 39186666
This article explores the essential elements for achieving excellence in international collaborations within health professions education (HPE), drawing on the Association for Medical Education in Europe (AMEE) ASPIRE Award criteria...
3.
Nielsen A, Hemmig A, de Thurah A, Schmidt W, Sattui S, Mackie S, et al.
Semin Arthritis Rheum
. 2023 Aug;
63:152260.
PMID: 37639896
Introduction: Prompt diagnosis and treatment of polymyalgia rheumatica (PMR) is crucial to prevent long-term complications and improve patient outcomes. However, there is currently no standardized approach to referral of suspected...
4.
van der Geest K, Treglia G, Glaudemans A, Brouwer E, Sandovici M, Jamar F, et al.
Eur J Nucl Med Mol Imaging
. 2021 May;
48(12):3886-3902.
PMID: 33942141
Purpose: Monitoring disease activity in patients with large vessel vasculitis (LVV) can be challenging. [18F]FDG-PET/CT is increasingly used to evaluate treatment response in LVV. In this systematic review and meta-analysis,...
5.
Diagnostic value of [18F]FDG-PET/CT in polymyalgia rheumatica: a systematic review and meta-analysis
van der Geest K, Treglia G, Glaudemans A, Brouwer E, Jamar F, Slart R, et al.
Eur J Nucl Med Mol Imaging
. 2020 Dec;
48(6):1876-1889.
PMID: 33372248
Purpose: Polymyalgia rheumatica (PMR) can be difficult to diagnose. Whole-body [18F]FDG-PET/CT allows for a comprehensive evaluation of all relevant articular and extra-articular structures affected by PMR. We aimed to summarize...
6.
Abdulle A, Arends S, van Goor H, Brouwer E, van Roon A, Westra J, et al.
Scand J Rheumatol
. 2020 Oct;
50(2):153-160.
PMID: 33063580
: Low body weight is an easily assessable cause of Raynaud's phenomenon (RP), and is frequently overlooked by clinicians. We aim to investigate the association of low body weight (body...
7.
Dos Santos J, Artigiani Neto R, Mangueira C, Filippi R, Gutierrez P, Westra J, et al.
Clin Exp Immunol
. 2020 Jul;
202(3):384-393.
PMID: 32639582
Takayasu arteritis (TAK) is a large-vessel granulomatous vasculitis; the inflammatory infiltration in arteries comprises macrophages, multi-nucleated giant cells, CD4 and CD8 T cells, γδ T cells, natural killer (NK) cells...
8.
Buurman D, Blokzijl T, Festen E, Pham B, Faber K, Brouwer E, et al.
PLoS One
. 2018 Dec;
13(12):e0208922.
PMID: 30533022
Introduction: TNF-α-neutralizing antibodies, such as infliximab (IFX) and adalimumab (ADA), are effective in the treatment of inflammatory bowel diseases (IBD), but they are expensive and become ineffective when patients develop...
9.
Arends S, Trouw L, Toes R, van Zanten A, Roozendaal C, Limburg P, et al.
Ann Rheum Dis
. 2017 Mar;
76(11):e43.
PMID: 28274913
No abstract available.
10.
van Zanten A, Arends S, Roozendaal C, Limburg P, Maas F, Trouw L, et al.
Ann Rheum Dis
. 2017 Jan;
76(7):1184-1190.
PMID: 28043998
Objectives: To determine the prevalence of anticitrullinated protein antibodies (ACPAs) and their association with known rheumatoid arthritis (RA) risk factors in the general population. Methods: Lifelines is a multidisciplinary prospective...